Clinical trial results announced at the Transcatheter Therapeutics conference in San Francisco headlined the medtech research and development news last week. Noteworthy "commercial" developments in late October include iCad’s decision to sell its Xoft brachytherapy business to Elekta and Butterfly Network's plans to work with Forest Neurotech on brain-computer interfaces.

He may not be Ali, but Butterfly Network's new CEO, Joseph DeVivo, believes Butterly’s microchip tech packs a formidable punch. He expects the company’s technology will help it transcend the market-development challenges the company faced under its previous leaderships.

The handheld ultrasound company made a loss last quarter, but secured FDA authorization for a new ultrasound software and named new leadership.

Medtech Insight talked to Sachita Shah, Butterfly Network's director of global health, and John Martin, the company's chief medical officer, to learn more about how point-of-care ultrasound can benefit rural, underserved communities in Sub-Saharan Africa by helping to reduce maternal mortality and childbirth-related complications.